This policy watch piece highlights the potential challenges surrounding COVID-19 vaccinations among Hispanic people, whose health and finances have been extremely hard hit by the pandemic. Low rates of vaccination among Hispanic people would leave them at increased risk for the virus, could further widen existing health disparities, and would leave gaps that hinder our ability to achieve overall population immunity.
- view as grid
- view as list
The COVID-19 pandemic has underscored the stark racial and ethnic health inequities in the U.S., including among Medicare beneficiaries. Among this group, people of color, including older adults and others on Medicare, account for disproportionate shares of COVID-19 cases, hospitalizations and deaths, according to data presented in a new KFF…
This chart collection draws on primary and secondary data analyses by KFF and other sources to examine the characteristics, experiences, and outcomes of the Medicare population by race and ethnicity
Updated analysis of state-reported data as of February 1, 2021 on COVID-19 vaccinations, cases, and deaths by race/ethnicity is now available. Based on nearly half of states reporting vaccination data by race/ethnicity, Black and Hispanic people continue to receive smaller shares of vaccinations compared to their shares of cases and…
Public Perspectives on Women’s Health Policy Priorities for the Biden-Harris Administration and Congress
The KFF Women’s Health Survey asked respondents how much of a priority seven key women’s health policies should be for the new President and Congress. This issue brief examines attitudes toward those policy priorities and differences by gender, political party affiliation, and demographic factors.
Vaccine Monitor: Nearly Half of the Public Wants to Get a COVID-19 Vaccine as Soon as They Can or Has Already Been Vaccinated, Up across Racial and Ethnic Groups Since December
Most Convincing Messages to Promote Vaccination Highlight Effectiveness at Preventing Illness and a Return to Normal Life; Hearing about Rare Allergic Reactions and Side Effects May Discourage Some New KFF Dashboard Features Key Data and Insights from the Vaccine Monitor With millions of Americans getting their first COVID-19 vaccinations, the…
This brief reviews why racial diversity within COVID-19 vaccine clinical trials is important, discusses the barriers to participation in clinical trials among people of color, and examines the racial/ethnic composition of clinical trial participants for the Pfizer-BioNTech and Moderna vaccines.
During the 52nd week since the first coronavirus case appeared in the United States, the U.S. surpassed 24.6 million total cases and 410,100 deaths due to the pandemic. Here’s our recap of the past week in the coronavirus pandemic from our tracking, policy analysis, polling, and journalism.
A new Policy Watch, Early State Vaccination Data Raise Warning Flags for Racial Equity, explores the latest state-reported data on vaccination by race/ethnicity available on KFF’s COVID-19 state data and policy tracker. As of January 19, 2021, 17 states were reporting some vaccination data by race/ethnicity, including 16 states reporting…
Across states, data to understand access to and uptake of the vaccine by race/ethnicity and other demographic factors will be central to efforts to ensure equity. KFF is compiling and will regularly update state-reported data on vaccination by race/ethnicity through its COVID-19 state data and policy tracker.